Washington, D.C. – A recent study conducted by researchers at the University of Basel has found that the approval of medical marijuana has had little impact on the mental health of the general population in the United States. However, the legalization of cannabis for therapeutic purposes has shown benefits for those who require it. The study aimed to determine the effects of medical cannabis legislation on the well-being of specific groups and its therapeutic value.
Since the mid-1990s, most states in the U.S. have made access to marijuana easier, either through medical clearance or the decriminalization of recreational use. Nevertheless, the issue of marijuana liberalization remains controversial. Some individuals express concerns about potential addiction, while others advocate for its medical benefits in treating chronic pain, nausea, and convulsions.
To conduct their analysis, the researchers utilized two large datasets. The first dataset included nearly eight million survey participants from 1993 to 2018 as part of the Behavioral Risk Factor Surveillance System, which collects data on mental well-being. The second dataset was from the National Survey on Drug Use and Health, which focuses on health-related issues and drug use in the United States.
Different groups were formed using statistical assignment, including individuals who were likely to abstain from marijuana use, use it recreationally, or use it for medical reasons. The researchers were also able to identify individuals with a high probability of experiencing chronic pain. Mental health was assessed through self-assessment, where respondents reported the number of days in the previous month that they had experienced mental health problems.
The researchers employed statistical methods to estimate the impact of the legal approval of medical marijuana. The findings revealed that easier access to marijuana for medical purposes improved the mental health of individuals who used it for medical reasons or who were likely to suffer from chronic pain. These groups reported spending 0.3 days less per month in poor mental health as a result of the legalization. However, the study did not find any significant effects on the mental health of recreational users or younger populations.
“In summary, our results demonstrate that medical cannabis legislation in the U.S. benefits the intended groups without harming others,” stated Prof. Alois Stutzer, the study leader from the University of Basel.
This study sheds light on the impact of medical marijuana legislation on mental health, emphasizing its positive effects on specific groups while dispelling concerns about negative consequences for the general population. As debates surrounding marijuana legalization continue, further research on its therapeutic value and potential risks will be essential in shaping future policies.
The study, titled “Medical marijuana laws and mental health in the United States,” was published in the journal Health Economics, Policy and Law.
Note: This article was written using AP News Style and does not quote any news organization.